Summary
For the prevention of recurrent embolic stroke, 23 elderly patients with non-valvular atrial fibrillation (NVAF) were treated with oral anticoagulants (warfarin) during a mean period of 3.8 years. Only one patient suffered recurrent embolism, and another had acute myocardial infarction. There was no cerebral haemorrhage during the treatment. In an untreated control group (from an autopsy series), recurrent embolic strokes occurred in 18 of 70 NVAF patients (26%) during a mean period of 1.3 years. Long-term anticoagulant therapy appears to be effective in the prevention of recurrent embolic stroke in elderly patients with NVAF.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams GF, Merrett JD, Hutchinson WM, Pollock AM (1974) Cerebral embolism and mitral stenosis: survival with and without anticoagulants. J Neurol Neurosurg Psychiatry 37:373–383
Asky JM, Cherry CB (1950) Thromboembolism associated with auricular fibrillation. Continuous anticoagulant therapy. JAMA 144:97–100
Britton M, Gustafsson C (1985) Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke 16:182–188
Calandre L, Ortega JF, Bermejo F, Portera A (1983) Cerebral embolism and anticoagulation. Neurology 33:1103–1104
Carter AB (1965) Prognosis of cerebral embolism. Lancet II:514–519
Cerebral embolism study group (1983) Immediate anticoagulation of embolic stroke: a randomized trial. Stroke 14:668–676
Cerebral embolism study group (1984) Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 15:779–789
Cosgriff SW (1950) Prophylaxis of recurrent embolism of intracardiac origin. Protracted anticoagulant therapy on an ambulatory basis. JAMA 143:870–872
Cosgriff SW (1953) Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann Inter Med 38:278–287
Drake ME, Shin C (1983) Conversion of ischemic to hemorrhagic infarction by anticoagulant administration. Report of two cases with evidence from serial computed tomographic brain scans. Arch Neurol 40:44–46
Fleming HA, Bailey SM (1971) Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 47:599–604
Furlan AJ, Cavalier SJ, Hobbs RE, Weinstein MA, Modic MT (1982) Hemorrhage and anticoagulation after nonseptic embolic brain infarction. Neurology 32:280–282
Hart RG, Coull BM, Hart D (1983) Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke 14:688–693
Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM (1977) Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 40:509–513
Kelley RE, Berger JR, Alter M, Kovacs AG (1984) Cerebral ischemia and atrial fibrillation: prospective study. Neurology 34:1285–1291
Koller RL (1982) Recurrent embolic cerebral infarction and anticoagulation. Neurology 32:283–285
Kuramoto K, Matsushita S, Yamanouchi H (1984) Atrial fibrillation as a cause of myocardial and cerebral infarctions. Jpn Circ J 48:67–74
Lieberman A, Hass WK, Pinto R, Ismo WO, Kupersmith M, Bear G, Chase R (1978) Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves. Stroke 9:18–24
Lodder J, Lugt PJM van der (1983) Evaluation of the risk of immediate anticoagulant treatment in patients with embolic stroke of cardiac origin. Stroke 14:42–46
Martin GJ, Biller J (1984) Nonseptic cerebral emboli of cardiac origin. Arch Int Med 144:1997–1999
Ott BR, Zamani A, Kleefield J, Funkenstein HH (1986) The clinical spectrum of hemorrhagic infarction. Stroke 17:630–637
Pastor BH, Resnick ME, Rodman T (1962) Serious hemorrhagic complications of anticoagulant therapy. JAMA 180:747–751
Ramirez-Lassepas M, Quinones M (1984) Heparin therapy for stroke: hemorrhagic complications and risk factors for intracerebral hemorrhage. Neurology 34:114–117
Ruff RL, Dougherty Jr JH (1981) Evaluation of acute cerebral ischemia for anticoagulant therapy: computed tomography or lumbar puncture. Neurology 31:736–740
Sage JI, Uitert RL van (1983) Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease. Stroke 14:537–540
Sherman DG, Goldman L, Whiting RB, Jurgensen K, Kaste M, Easton JD (1984) Thromboembolism in patients with atrial fibrillation. Arch Neurol 41:708–710
Shields Jr RW, Laureno R, Lachman T, Victor M (1984) Anticoagulant-related hemorrhage in acute cerebral embolism. Stroke 15:426–437
Szekely P (1964) Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. Br Med J 1:1209–1212
Wintzen AR, Jonge H de, Loeliger EA, Bots GTAM (1984) The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol 16:553–558
Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28:973–977
Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM (1983) Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke 14:664–667
Wright IS, McDevitt E (1954) Cerebral vascular diseases: their significance, diagnosis, and present treatment, including the selective use of anticoagulant substances. Lancet II:825–830
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamanouchi, H., Nagura, H., Ohkawa, Y. et al. Anticoagulant therapy in recurrent cerebral embolism: a retrospective study in non-valvular atrial fibrillation. J Neurol 235, 407–410 (1988). https://doi.org/10.1007/BF00314482
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314482